Faraday cup for commissioning and quality assurance for proton pencil beam scanning beams at conventional and ultra-high dose rates.

Faraday cup dosimetry proton therapy ultra-high dose rate

Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 17 12 2020
accepted: 27 04 2021
pubmed: 28 4 2021
medline: 15 12 2021
entrez: 27 4 2021
Statut: epublish

Résumé

Recently, proton therapy treatments delivered with ultra-high dose rates have been of high scientific interest, and the Faraday cup (FC) is a promising dosimetry tool for such experiments. Different institutes use different FC designs, and either a high voltage guard ring, or the combination of an electric and a magnetic field is employed to minimize the effect of secondary electrons. The authors first investigate these different approaches for beam energies of 70, 150, 230 and 250 MeV, magnetic fields between 0 and 24 mT and voltages between -1000 and 1000 V. When applying a magnetic field, the measured signal is independent of the guard ring voltage, indicating that this setting minimizes the effect of secondary electrons on the reading of the FC. Without magnetic field, applying the negative voltage however decreases the signal by an energy dependent factor up to 1.3% for the lowest energy tested and 0.4% for the highest energy, showing an energy dependent response. Next, the study demonstrates the application of the FC up to ultra-high dose rates. FC measurements with cyclotron currents up to 800 nA (dose rates of up to approximately 1000 Gy s

Identifiants

pubmed: 33906166
doi: 10.1088/1361-6560/abfbf2
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 Institute of Physics and Engineering in Medicine.

Auteurs

C Winterhalter (C)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.
Physics Department, ETH Zurich, Switzerland.

M Togno (M)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

K P Nesteruk (KP)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

F Emert (F)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

S Psoroulas (S)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

M Vidal (M)

Institut Mediterraneen de Protontherapie, Centre Antoine Lacassagne, Nice, France.

D Meer (D)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

D C Weber (DC)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.
Radiation Oncology Department of the University Hospital of Bern, Switzerland.
Radiation Oncology Department of the University Hospital of Zürich, Switzerland.

A Lomax (A)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.
Physics Department, ETH Zurich, Switzerland.

S Safai (S)

Centre for Proton Therapy, Paul Scherrer Institute, Switzerland.

Articles similaires

Humans Middle Aged Female Male Surveys and Questionnaires
Adolescent Child Female Humans Male
Humans Scoliosis Mobile Applications Retrospective Studies Artificial Intelligence

Classifications MeSH